The anthelmintic effects of pyrantel pamoate, oxantel-pyrantel pamoate, levamisole and mebendazole in the treatment of intestinal nematodes.
D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use; D001196:Ascariasis / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002648:Child; D003365:Costs and Cost Analysis; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy* / Q000191:economics; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D008463:Mebendazole / Q000627:therapeutic use*; D009332:Necatoriasis / Q000188:drug therapy; D011715:Pyrantel / Q000031:analogs & derivatives*; D011716:Pyrantel Pamoate / Q000627:therapeutic use*; D014257:Trichuriasis / Q000188:drug therapy
D000871:Anthelmintics; D001562:Benzimidazoles; D007978:Levamisole; D011715:Pyrantel; D011716:Pyrantel Pamoate; D008463:Mebendazole